HHS recommends changing cannabis from a Schedule I Schedule III drug under the Controlled Substances Act.
Related Posts
Analysis: Most Commercially Available CBD Products Mislabeled, Make Misleading Claims
These findings highlight the need for proper regulatory oversight of cannabinoid-containing products to ensure quality assurance and deter …
What marijuana reclassification means for the US cannabis industry – Yahoo Finance
Curaleaf CEO Matt Darin said it was “a historic moment” for the cannabis industry following reports that the DEA is seeking to reschedule …
GOP-Led Congressional Committee Approves Bill To Ban Most Consumable Hemp …
Supporters of the ban have described the language as a fix to a “loophole” that was created under the 2018 Farm Bill that federally legalized […]